Reverse-iT One-Step Kit, ReddyMix from ABgene
Description:The Reverse-iT One-Step Kit is the ultimate in convenience, sensitivity and reproducibility in RT-PCR. It has been specifically designed to streamline the RT-PCR process. The Reverse-iT One-Step Kit combines the unique Reverse-iT Blend of RTases and ABgene®s Thermoprime Plus DNA Polymerase to provide a highly sensitive, reproducible and easy-to-use system for the det...10 x ReddyRun Gel Loading Buffer from ABgene
Description:dye and precipitant with the same buffer composition used in ReddyRun molecular weight markers. It is the same dye...Dr Reddy’s Laboratories to challenge patents on drug
Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal and gastric ulcers. The FDA granted the marketing exclusivity to Andrx group of the US....Dr Reddy’s Laboratories launches Hyalosy
The Hyderabad-based Dr Reddy’s Laboratories has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that provides relief from knee-joint stiffness and immobility among patients suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent disease. More than 90 per cent of people above the age of 45 are estimated to show signs of this disease, and it is the leading ca...AAI Pharma Files Lawsuit Against Dr. Reddy's Laboratories
Dr. Reddy's Laboratories (DRL) has been slapped with a lawsuit for patent infringement by the US based AAI Pharma Inc for the generic version of the anti-depressant drug Prozac. DRL has a 180 days exclusivity to sell the drug's 40 mg dosage form along with Barr Laboratories that holds the exclusivity for the 10 and 20 mg dosage forms. DRL expects this to be a routine move as the para IV filing af...Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
Dr Reddy's Laboratories Thursday announced it had entered a co-development and commercialisation agreement with Denmark-based Rheoscience A/S for the joint development of a drug to treat diabetes. // Under the pact, Rheoscience will fund all costs associated with the Phase-III clinical trials of balaglitazone (DRF 2593), a partial PPAR-gamma agonist, for the treatment of type 2 diabe...Dr Reddy's Launches Generic Version Of Mercks Proscar Tablets
Pharma major Dr Reddy's Laboratories today announced that it has launched the authorized generic version of Merck's Proscar tablets 5 mg (Finasteride) on June 19. // The company has also launched the authorized generic version of Merck's Zocor tablets (Simvastatin) 5 mg, 10 mg, 20 mg, 40 mg and 80 mg yesterday, a company release said. In January this year, the company ente...